Director, Global Indication Lead, Rheumatology

Director, Global Indication Lead, Rheumatology

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.

To help realize our ambitions, the argenx Global Commercial Team is looking for a Director, Global Indication Lead, Rheumatology.

In this key role, you will be responsible for leading the development of the commercial strategy for our key asset in one or multiple late-stage clinical development programs which include for example Sjogren's Disease and Myositis. You will guide the development and integrated execution of pre-launch efforts of the cross-functional Indication Commercialization Team in/for the assigned indication(s).

This role can be based virtually or on-site, ideally within proximity to one of our European, or East Coast US based hubs.

Roles and Responsibilities:

• Lead the development and execution of launch and commercialization strategies, focusing on key global and priority markets/regions.
• Build an integrated global indication brand strategy that considers short- and long-term brand/franchise impacts, ensuring strong alignment and integration across cross-functional teams, regional and country perspectives.
• Evolve the target patient profile, utilizing deep market insights to bring the patient journey to life and inform brand positioning to meet patient and HCP needs.
• Lead the insight-driven development of branding, messaging, and market activation strategies to maximize launch impact and sustained commercial success.
• Drive the development of the global launch campaign, co-creating it with key market stakeholders to ensure it is culturally relevant, distinctive, and enduring
• Identify strategic partnerships and collaborations to establish and enhance the brands, and argenx', market position
• Lead the cross-functional Indication Commercialization Team (ICT), responsible for defining the commercial product strategy throughout its lifecycle
• Foster ongoing insights development by collaborating internally and externally, ensuring data-driven decision-making for the brand
• Be the voice of the cross-functional Indication Commercialization Team (ICT) on the Indication Development Team (IDT), working closely with our Clinical Science and Development colleagues' to inform development strategy and efforts to maximize the value of our evidence generation efforts.
• Partner with Market Access & Pricing teams to optimize reimbursement strategies and support global market entry
• Monitor and analyse market trends, competitive landscape, and industry developments to inform brand strategy adjustments
• Represent argenx' at industry conferences and build relationships with key opinion leaders and other key stakeholders
• Manage the global commercial budget, ensuring optimal resource allocation to maximize brand impact
• Ensure that strategy and business assumptions are executable at in- and above market level and align with corporate priorities and cultural pillars
• Develop and communicate strategic options to optimize trade-offs, balancing risk, and global value considerations

Basic Qualifications:

• Master's degree and 10+ years of marketing experience
• 5+ years of experience in global strategic marketing/commercial roles, together with robust (3+ years) in-market and/or regional commercial leadership experience.
• Global brand launch and commercialization expertise, particularly for pipeline products and late-stage assets with multiple indications

• MBA in business or health sciences or additional education in biology, chemistry, life sciences preferred

Preferred Qualifications:

• Deep understanding of (auto)immune and rare diseases, with experience in Rheumatology, or other Immunology therapeutic areas being highly preferred
• Deep understanding of the legal, regulatory and commercial environment across major global markets (US, EU, Japan) highly preferred
• US in-market commercial launch experience preferred.
• Ability to lead and execute integrated, cross-functional commercialization strategies
• Experience leading teams in a matrixed environment, ensuring strategic and executional alignment, while comfortable with team based co-creation and decision making
• Strong agency management experience
• Strong analytical skills with the ability to synthesize market insights and make objective, data-driven decisions
• Expertise in market access, pricing, and reimbursement strategies across global markets